FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: opalapril who started this subject	6/4/2004 1:32:00 PM
From: Edscharp	of 75

Opal, Don't know if you're still around, but I've concluded that there is no such thing as 'lower-risk biotech investing'. It's all a crap shoot. No matter what drug or medication is being tested the science behind the effort and the requirements of the FDA make the process too uncertain to invest in. Now, as a gamble; that is a different story. Perhaps in time after the Human genome information has been digested and analyzed a better more reliable process for drug discovery may be achieved, but that is still in the future. For a brief while I hoped companies like Vical or Isis would be able to achieve such an understanding, but like the other 95% of the biotechs they have come up short in their efforts. For the average investor who is interested in biotech I would suggest investing into those few biotechs that seem to have a record of success. Genentech would be one. Biogen another. Perhaps there are a few others. Not many make the list. Biotech is a wasteland. Regards, Ed S.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next